[{"NetIncomeLoss_1_Q2_USD":-20630000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.85,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q2_pure":0.85,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.011,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q2_pure":0.011,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-40000.0,"Depreciation_2_Q2_USD":21000.0,"Depreciation_1_Q2_USD":11000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":229000.0,"AssetsCurrent_0_Q2_USD":92673000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-21000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":12350660.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":15840564.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":223000.0,"IncomeTaxesPaidNet_2_Q2_USD":33000.0,"CommonStockSharesIssued_0_Q2_shares":12358517.0,"Assets_0_Q2_USD":94377000.0,"ShareBasedCompensation_2_Q2_USD":6159000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":946000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":17251240.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":19632000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":78000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":113000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":12011199.0,"GeneralAndAdministrativeExpense_1_Q2_USD":6424000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":12289000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":28102000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":14149000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":1084000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-52000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":77000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":48000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":77000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":9000.0,"CommonStockValue_0_Q2_USD":12000.0,"OtherReceivablesNetCurrent_0_Q2_USD":297000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":123000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":20693000.0,"OtherAssetsCurrent_0_Q2_USD":626000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":7913000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":2882000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-657000.0,"OtherAssetsNoncurrent_0_Q2_USD":687000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":90690000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":650000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":971388000.0,"Cash_0_Q2_USD":2008000.0,"Liabilities_0_Q2_USD":10111000.0,"OperatingLeaseLiability_0_Q2_USD":1006000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"MoneyMarketFundsAtCarryingValue_0_Q2_USD":88682000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":58000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-310000.0,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"OperatingIncomeLoss_2_Q2_USD":-40391000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-20621000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3228000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-33966000.0,"ProceedsFromWarrantExercises_2_Q2_USD":660000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":402000.0,"LiabilitiesCurrent_0_Q2_USD":9461000.0,"AccountsPayableCurrent_0_Q2_USD":1548000.0,"NonoperatingIncomeExpense_2_Q2_USD":-77000.0,"NonoperatingIncomeExpense_1_Q2_USD":-48000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":90990000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":1983000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.83,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q2_pure":0.83,"ProceedsFromStockOptionsExercised_2_Q2_USD":401000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":83000.0,"ShortTermLeaseCost_2_Q2_USD":13000.0,"ShortTermLeaseCost_1_Q2_USD":6000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.005,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q2_pure":0.008,"OperatingLeasePayments_2_Q2_USD":115000.0,"OperatingLeasePayments_1_Q2_USD":58000.0,"PrepaidInsurance_0_Q2_USD":241000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":71000.0,"NetIncomeLoss_2_Q2_USD":-40545000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-40468000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":172000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":330000.0,"FederalIncomeTaxExpenseBenefitContinuingOperations_2_Q2_USD":0.0,"OperatingIncomeLoss_1_Q2_USD":-20573000.0,"PreferredStockValue_0_Q2_USD":null,"OperatingLeaseCost_2_Q2_USD":118000.0,"OperatingLeaseCost_1_Q2_USD":75000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":94377000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":6159000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3228000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":401000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":356000.0,"OperatingExpenses_2_Q2_USD":40391000.0,"OperatingExpenses_1_Q2_USD":20573000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":623000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":730000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-3.38,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.67,"ProfitLoss_2_Q2_USD":-40545000.0,"StockholdersEquity_0_Q2_USD":84266000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":40000.0,"RestrictedCashAndCashEquivalents_0_Q2_USD":300000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-887134000.0,"LeaseCost_2_Q2_USD":131000.0,"LeaseCost_1_Q2_USD":81000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-13365000.0,"CommonStockSharesOutstanding_0_Q2_shares":12358517.0,"FederalIncomeTaxExpenseBenefitContinuingOperations_1_Q2_USD":0.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":1576000.0,"Ticker":"SRRA","CIK":"1290149","name":"SIERRA ONCOLOGY, INC.","OfficialName":"Sierra Oncology Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1244659116.0","Country":"Canada","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]